Evidence that the hypothalamus may be a source of a circulating Na+-K+-ATPase inhibitor

in Journal of Endocrinology
Authors:
J. Alaghband-Zadeh
Search for other papers by J. Alaghband-Zadeh in
Current site
Google Scholar
PubMed
Close
,
S. Fenton
Search for other papers by S. Fenton in
Current site
Google Scholar
PubMed
Close
,
K. Hancock
Search for other papers by K. Hancock in
Current site
Google Scholar
PubMed
Close
,
J. Millettt
Search for other papers by J. Millettt in
Current site
Google Scholar
PubMed
Close
, and
H. E. de Wardener
Search for other papers by H. E. de Wardener in
Current site
Google Scholar
PubMed
Close
Restricted access
Rent on DeepDyve

Sign up for journal news

Acetone extracts from a variety of rat tissues were tested for their ability to stimulate renal glucose-6-phosphate dehydrogenase (G6PD) activity at 2 min in an in-vitro cytochemical assay which is a marker of the sodium potassium-dependent adenosine triphosphatase (Na+-K+-ATPase) inhibiting activity. Extracts of the hypothalamus were the only ones found to be active in this system. Acetone extract of hypothalamus also inhibited renal Na+-K+-ATPase activity in vitro. The G6PD-stimulating activity from one hypothalamus was about 10000 to 100 000 times greater than that of 1 ml plasma. The G6PD-stimulating activity of hypothalamic extracts from rats which had been on a high sodium intake for 4 weeks were approximately 150 times more active than those obtained from rats which had been on a low sodium diet. The G6PD-stimulating activity of the corresponding plasma was sixfold more active. These findings suggest that a circulating sodium transport inhibitor(s) may be secreted from the hypothalamus.

 

  • Collapse
  • Expand